Simplify Logo

Full-Time

Associate Manager of Internal Audit

Posted on 6/18/2024

Legend Biotech

Legend Biotech

1,001-5,000 employees

Develops and commercializes cell therapies

Hardware
Biotechnology

Mid

Somerset County, NJ, USA

Category
Auditing
Accounting
Required Skills
Data Analysis
Requirements
  • Bachelor’s degree from an accredited college / university
  • Masters, MBA, or CPA, CIA, CISA, CISM strongly preferred
  • Minimum 4 years of experience in auditing (combination of internal and/or external)
  • Experience with Sarbanes-Oxley (SOX) is required
  • Experience with operational audits is preferred
  • Experience in Public Accounting is required
  • Experience in the industries of pharmaceutical, life science, biotech is strongly preferred
  • Experience in manufacturing is strongly preferred
  • Experience in any of the following: risk assessment, data analytics tools (Galvanize/Diligent and ACL) is preferred
  • Excel/Word/PowerPoint capability required
  • Experience working with audit and data analytics
  • Ability to work independently, objectively and collaboratively in a fast-paced and matrixed team environment
  • Ability to manage multiple projects simultaneously and meet deadline requirements
  • Ability to learn new areas quickly and take ownership to execute projects
  • Ability to articulate issues and remediations clearly and concisely, supported by factual details, both written and verbal
  • Process-oriented and control-driven with strong analytical skills
  • Knowledge of U.S. GAAP & IFRS and IIA standards is required
Responsibilities
  • Manage audit risk assessment and develop risk-based audit programs
  • Manage audit lifecycle from planning to reporting
  • Interview key process owners to assess business processes and control environments
  • Leverage data analysis in risk assessment and audit execution
  • Identify control gaps and improvement opportunities
  • Evaluate risks and potential business impact of deficiencies
  • Document audit workpapers and test conclusions
  • Align audit findings with process owners and operationalize remediation plans
  • Track audit deficiencies and ensure completion of remediations
  • Build strong relationships with business functions and provide expert insights
  • Assist in training and coaching senior and junior auditors

Legend Biotech develops and sells cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's own cells to combat cancer. Unlike many competitors, Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments. Their goal is to provide effective treatments for hard-to-treat diseases through innovative cell therapy solutions.

Company Stage

IPO

Total Funding

$750.5M

Headquarters

Franklin Township, New Jersey

Founded

2014

Growth & Insights
Headcount

6 month growth

17%

1 year growth

38%

2 year growth

95%
Simplify Jobs

Simplify's Take

What believers are saying

  • Legend Biotech's recent European Commission approval for CARVYKTI® positions it as a leader in the multiple myeloma treatment market.
  • Strategic partnerships, such as the one with MaxCyte, enhance Legend Biotech's capabilities in cell engineering and expand its technological reach.
  • The company's commitment to transparency and investor relations, demonstrated through regular financial updates, fosters investor confidence and long-term stability.

What critics are saying

  • The competitive landscape in cell therapy and personalized medicine is intense, requiring continuous innovation to maintain market position.
  • Regulatory hurdles and the need for extensive clinical trials can delay the commercialization of new therapies, impacting revenue streams.

What makes Legend Biotech unique

  • Legend Biotech's technology-agnostic approach allows it to explore multiple innovative therapies, unlike competitors who may focus on a single technology.
  • The company's comprehensive business model, from discovery to commercialization, ensures control over the entire treatment lifecycle, providing a competitive edge.
  • Legend Biotech's strong focus on CAR-T therapies, particularly for hematological malignancies and solid tumors, sets it apart in the personalized medicine sector.
INACTIVE